<table width="500" xmlns="urn:hl7-org:v3" xmlns:voc="http://www.hl7.org/v3/voc" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"><caption>TABLE 1: Summary of Tumor Responses</caption>
<tbody>
<tr><td></td><td align="center" colspan="2">STUDY 1</td><td align="center" colspan="2">STUDY 2</td></tr>
<tr><td></td><td align="center"><paragraph>Panretin®<br/>Gel<br/></paragraph>N=134</td><td align="center"><paragraph>Vehicle <br/>Gel</paragraph>N=134</td><td align="center"><paragraph>Panretin®<br/>Gel<br/></paragraph>N=36</td><td align="center"><paragraph>Vehicle <br/>Gel</paragraph>N=46</td></tr>
<tr><td><paragraph><br/>Modified ACTG Response</paragraph><paragraph>(index lesions)</paragraph></td><td align="center"><paragraph><br/>34% PR</paragraph>1% CR</td><td align="center"><paragraph><br/>16% PR</paragraph>
												p=0.0012</td><td align="center"><br/>36% PR</td><td align="center"><br/>7% PR</td></tr>
<tr><td><paragraph><br/><br/>Physician's Global/Subjective Assessment</paragraph><paragraph>(all treated lesions)</paragraph></td><td align="center"><br/>19% PR</td><td align="center"><paragraph><br/>4% PR</paragraph>
												p=0.00014</td><td align="center"><br/>47% PR</td><td align="center"><br/>11% PR</td></tr>
<tr><td><paragraph><br/><br/>Beneficial Response Photographs</paragraph><paragraph>(index lesions only)</paragraph></td><td align="center"><br/>15%</td><td align="center"><paragraph><br/>4%</paragraph>
												p=0.0026</td><td align="center"><br/>19%</td><td align="center"><br/>2%</td></tr>
</tbody>
</table>